Products - Antimicrobial stewardship | Topic | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Showing 45 products

Date | Title

Urinary tract infection (recurrent): antimicrobial prescribing (NG112)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
12 December 2024
Published:
31 October 2018
Neonatal infection: antibiotics for prevention and treatment (NG195)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
19 March 2024
Published:
20 April 2021
Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies: early value assessment (HTE6)
Product type:
Guidance
Programme:
Health technology evaluation
Last updated:
10 August 2023
Published:
30 March 2023
Point-of-care tests for urinary tract infections to improve antimicrobial prescribing: early value assessment (HTE7)
Product type:
Guidance
Programme:
Health technology evaluation
Published:
4 May 2023
Cefiderocol for treating severe drug-resistant gram-negative bacterial infections (HTE2)
Product type:
Guidance
Programme:
Health technology evaluation
Published:
17 August 2022
Ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections (HTE1)
Product type:
Guidance
Programme:
Health technology evaluation
Published:
17 August 2022
Otitis media (acute): antimicrobial prescribing (NG91)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
11 March 2022
Published:
28 March 2018
Clostridioides difficile infection: antimicrobial prescribing (NG199)
Product type:
Guidance
Programme:
NICE guideline
Published:
23 July 2021
Secondary bacterial infection of eczema and other common skin conditions: antimicrobial prescribing (NG190)
Product type:
Guidance
Programme:
NICE guideline
Published:
2 March 2021
Human and animal bites: antimicrobial prescribing (NG184)
Product type:
Guidance
Programme:
NICE guideline
Published:
4 November 2020
Insect bites and stings: antimicrobial prescribing (NG182)
Product type:
Guidance
Programme:
NICE guideline
Published:
22 September 2020
Surgical site infections: prevention and treatment (NG125)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
19 August 2020
Published:
11 April 2019
Impetigo: antimicrobial prescribing (NG153)
Product type:
Guidance
Programme:
NICE guideline
Published:
26 February 2020
Leg ulcer infection: antimicrobial prescribing (NG152)
Product type:
Guidance
Programme:
NICE guideline
Published:
11 February 2020
Cellulitis and erysipelas: antimicrobial prescribing (NG141)
Product type:
Guidance
Programme:
NICE guideline
Published:
27 September 2019
Pneumonia (community-acquired): antimicrobial prescribing (NG138)
Product type:
Guidance
Programme:
NICE guideline
Published:
16 September 2019
Pneumonia (hospital-acquired): antimicrobial prescribing (NG139)
Product type:
Guidance
Programme:
NICE guideline
Published:
16 September 2019
Cough (acute): antimicrobial prescribing (NG120)
Product type:
Guidance
Programme:
NICE guideline
Published:
7 February 2019
Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing (NG117)
Product type:
Guidance
Programme:
NICE guideline
Published:
18 December 2018
Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing (NG114)
Product type:
Guidance
Programme:
NICE guideline
Published:
5 December 2018
Urinary tract infection (catheter-associated): antimicrobial prescribing (NG113)
Product type:
Guidance
Programme:
NICE guideline
Published:
23 November 2018
Prostatitis (acute): antimicrobial prescribing (NG110)
Product type:
Guidance
Programme:
NICE guideline
Published:
31 October 2018
Pyelonephritis (acute): antimicrobial prescribing (NG111)
Product type:
Guidance
Programme:
NICE guideline
Published:
31 October 2018
Urinary tract infection (lower): antimicrobial prescribing (NG109)
Product type:
Guidance
Programme:
NICE guideline
Published:
31 October 2018
Sore throat (acute): antimicrobial prescribing (NG84)
Product type:
Guidance
Programme:
NICE guideline
Published:
26 January 2018
Sinusitis (acute): antimicrobial prescribing (NG79)
Product type:
Guidance
Programme:
NICE guideline
Published:
27 October 2017
Antimicrobial stewardship: changing risk-related behaviours in the general population (NG63)
Product type:
Guidance
Programme:
NICE guideline
Published:
25 January 2017
Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use (NG15)
Product type:
Guidance
Programme:
NICE guideline
Published:
18 August 2015
Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adults (ES40)
Product type:
Advice
Programme:
Evidence summary
Published:
11 May 2022
Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infections (ES39)
Product type:
Advice
Programme:
Evidence summary
Published:
11 May 2022
Antimicrobial prescribing: delafloxacin for community-acquired pneumonia (ES37)
Product type:
Advice
Programme:
Evidence summary
Published:
10 August 2021
Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infections (ES32)
Product type:
Advice
Programme:
Evidence summary
Published:
5 January 2021
Antimicrobial prescribing: imipenem with cilastatin and relebactam (ES30)
Product type:
Advice
Programme:
Evidence summary
Published:
28 October 2020
Antimicrobial prescribing: ceftolozane with tazobactam for treating hospital-acquired pneumonia, including ventilator-associated pneumonia (ES22)
Product type:
Advice
Programme:
Evidence summary
Published:
18 December 2019
Antimicrobial prescribing: meropenem with vaborbactam (ES21)
Product type:
Advice
Programme:
Evidence summary
Published:
20 November 2019
Fungitell for antifungal treatment stratification (MIB118)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
31 August 2017
eazyplex SuperBug kits for detecting carbapenemase-producing organisms (MIB94)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
7 February 2017
Alere Afinion CRP for C-reactive protein testing in primary care (MIB81)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
14 September 2016
QuikRead go for C-reactive protein testing in primary care (MIB78)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
14 September 2016
Xpert Carba-R to identify people carrying carbapenemase-producing organisms (MIB52)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
12 February 2016
Clostridium difficile infection: risk with broad-spectrum antibiotics (ESMPB1)
Product type:
Advice
Programme:
Evidence summary
Published:
17 March 2015
Antimicrobial stewardship (QS121)
Product type:
Quality standard
Published:
22 April 2016
Suspected sepsis: recognition, diagnosis and early management
Status:
In development
Programme:
NICE guideline
Expected publication date:
13 August 2025
Managing common infections - antimicrobial prescribing guidelines
Status:
In development
Programme:
NICE guideline
Expected publication date:
TBC
Olorofim for treating invasive fungal infections in people 16 years and over [TSID11983]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC